Park Place Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$571K Buy
2,250
+173
+8% +$40.3K 0.09% 137
2026
Q1
$508K Sell
2,077
-1,577
-43% -$367K 0.1% 120
2025
Q4
$756K Sell
3,654
-1,256
-26% -$248K 0.16% 93
2025
Q3
$910K Buy
4,910
+619
+14% +$106K 0.19% 85
2025
Q2
$669K Sell
4,291
-484
-10% -$74.4K 0.15% 100
2025
Q1
$792K Sell
4,775
-2,164
-31% -$339K 0.21% 88
2024
Q4
$1M Buy
6,939
+963
+16% +$149K 0.28% 82
2024
Q3
$968K Buy
5,976
+1,112
+23% +$177K 0.28% 80
2024
Q2
$711K Buy
4,864
+1,338
+38% +$199K 0.23% 95
2024
Q1
$558K Buy
3,526
+1,369
+63% +$218K 0.2% 127
2023
Q4
$338K Sell
2,157
-849
-28% -$130K 0.13% 162
2023
Q3
$468K Sell
3,006
-1,329
-31% -$219K 0.14% 148
2023
Q2
$718K Sell
4,335
-65
-1% -$10.5K 0.2% 122
2023
Q1
$682K Sell
4,400
-333
-7% -$53.8K 0.19% 122
2022
Q4
$836K Buy
+4,733
New +$817K 0.24% 103

Other funds holding JNJ

Park Place Capital's JNJ Position: Q2 2026 in Review

Park Place Capital increased its Johnson & Johnson (JNJ) stake by 8.3% in Q2 2026, buying an estimated $40.3K and bringing the position to 2,250 shares worth $571K. The position accounts for 0.09% of the portfolio, ranked #137.

Park Place Capital first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $1M in Q4 2024. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Park Place Capital held 2,250 shares of Johnson & Johnson worth $571K as of Q2 2026.
  • Park Place Capital bought 173 Johnson & Johnson shares in Q2 2026, an estimated $40.3K.
  • Johnson & Johnson made up 0.09% of Park Place Capital's portfolio in Q2 2026, its #137 holding.
  • Park Place Capital first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Park Place Capital's Johnson & Johnson position peaked at $1M in Q4 2024.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.